CoChat

Neuropsychological Effects of Risperidone in Children with Pervasive Developmental Disorders: ABlinded Discontinuation Study

Open access
Troost, Pieter W., Althaus, Monika, Lahuis, Bertine E., Buitelaar, Jan K., Minderaa, Ruud B., Hoekstra, Pieter J. · 2006 · Journal of Child and Adolescent Psychopharmacology
Cited by 33

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Little is known about the neuropsychological effects of risperidone in children with pervasive developmental disorders. METHOD: Twenty-four children (aged 5-17 years) with pervasive developmental disorders and co-morbid disruptive behavior who responded favorably to open-label treatment with risperidone as part of a previously described controlled discontinuation study completed two different computerized attention tasks at baseline, weeks 4, 8, and 24 of open-label treatment, and, at 8 weeks after random assignment to either placebo or risperidone. The primary efficacy measures were response latencies to visually presented stimuli requiring two different types of attention-controlled processing, i.e., focused and divided attention. RESULTS: About half of the clinical responders did not produce valid performance measures. These could be shown to be of younger mental age and less adaptive as measured by the Vineland Behavior Scales. For the valid task performers divided attention (serial search in working memory) was shown to regress in the placebo group (n = 7), while in the risperidone group (n = 7) there was further improvement. No such group difference was found for focused attention. CONCLUSIONS: The study suggests a beneficial effect of risperidone after several months of treatment, enhancing divided attention in children with pervasive developmental disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/cap.2006.16.561

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 33

Metadata

Authors
Troost, P. W., Althaus, M., Lahuis, B. E., Buitelaar, J. K., Minderaa, R. B., & Hoekstra, P. J.
Venue
Journal of Child and Adolescent Psychopharmacology
Published
2006-10
Volume
16
Issue
5
Pages
561-573
ISSN
  • 1044-5463 (ISSN-L)
  • 1557-8992
OpenAlex
W2086495048
Cited by
33
References
7
FWCI
1.54
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neuropsychological Effects of Risperidone in Children with Pervasive Developmental Disorders: ABlinded Discontinuation Study. https://app.cochat.ai/papers/10.1089/cap.2006.16.561
The paper
Troost, P. W., Althaus, M., Lahuis, B. E., Buitelaar, J. K., Minderaa, R. B., & Hoekstra, P. J. (2006). Neuropsychological Effects of Risperidone in Children with Pervasive Developmental Disorders: ABlinded Discontinuation Study. Journal of Child and Adolescent Psychopharmacology. https://doi.org/10.1089/cap.2006.16.561

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.